Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fasting in obesity: another cause of liver injury with alcoholic hyaline?

Literature DB >> 6176409

Fasting in obesity: another cause of liver injury with alcoholic hyaline?

J P Capron, J Delamarre, J L Dupas, A Braillon, C Degott, C Quenum.

Abstract

Entities: Disease

Mesh：

Year: 1982 PMID： 6176409 DOI： 10.1007/BF01296926

Source DB: PubMed Journal: Dig Dis Sci ISSN： 0163-2116 Impact factor: 3.199

× No keyword cloud information.

21 in total

Review 1. Drug-induced chronic liver disease.

Authors: W C Maddrey; J K Boitnott
Journal: Gastroenterology Date: 1977-06 Impact factor: 22.682

2. Liver ultrastructure in abetalipoproteinemia: Evolution of micronodular cirrhosis.

Authors: J S Partin; J C Partin; W K Schubert; A J McAdams
Journal: Gastroenterology Date: 1974-07 Impact factor: 22.682

3. The liver in morbid obesity and following bypass surgery for obesity.

Authors: A T Marubbio; R D Rucker; P D Schneider; J P Horstmann; R L Varco; H Buchwald
Journal: Surg Clin North Am Date: 1979-12 Impact factor: 2.741

4. Drug effects on the liver: a tabular compilation of drugs and drug-related hepatic diseases.

Authors: J Ludwig
Journal: Dig Dis Sci Date: 1979-10 Impact factor: 3.199

5. Randomised trial of jejunoileal bypass versus medical treatment in morbid obesity. The Danish Obesity Project.

Authors:
Journal: Lancet Date: 1979-12-15 Impact factor: 79.321

6. Hepatic effects of jejunoileal bypass for morbid obesity.

Authors: R T Holzbach
Journal: Am J Clin Nutr Date: 1977-01 Impact factor: 7.045

7. Liver injury with alcoholic hyaline after intestinal resection.

Authors: D A Peura; F W Stromeyer; L F Johnson
Journal: Gastroenterology Date: 1980-07 Impact factor: 22.682

8. Pericentral hepatic fibrosis and intracellular hyalin in diabetes mellitus.

Authors: K R Falchuk; S C Fiske; R C Haggitt; M Federman; C Trey
Journal: Gastroenterology Date: 1980-03 Impact factor: 22.682

9. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.

Authors: J Ludwig; T R Viggiano; D B McGill; B J Oh
Journal: Mayo Clin Proc Date: 1980-07 Impact factor: 7.616

10. Fatty liver hepatitis and cirrhosis in obese patients.

Authors: M Adler; F Schaffner
Journal: Am J Med Date: 1979-11 Impact factor: 4.965

9 in total

Review 1. Practical management of the increasing burden of non-alcoholic fatty liver disease.

Authors: Angelina Mouralidarane; Ching-I Lin; Narin Suleyman; Junpei Soeda; Jude A Oben
Journal: Frontline Gastroenterol Date: 2010-09-23

2. Orlistat reverse fatty infiltration and improves hepatic fibrosis in obese patients with nonalcoholic steatohepatitis (NASH).

Authors: Osamah Hussein; Masha Grosovski; Sorina Schlesinger; Sergio Szvalb; Nimer Assy
Journal: Dig Dis Sci Date: 2007-04-03 Impact factor: 3.199

Fasting in obesity: another cause of liver injury with alcoholic hyaline?

Review 1. Drug-induced chronic liver disease.

2. Liver ultrastructure in abetalipoproteinemia: Evolution of micronodular cirrhosis.

3. The liver in morbid obesity and following bypass surgery for obesity.

4. Drug effects on the liver: a tabular compilation of drugs and drug-related hepatic diseases.

5. Randomised trial of jejunoileal bypass versus medical treatment in morbid obesity. The Danish Obesity Project.

6. Hepatic effects of jejunoileal bypass for morbid obesity.

7. Liver injury with alcoholic hyaline after intestinal resection.

8. Pericentral hepatic fibrosis and intracellular hyalin in diabetes mellitus.

9. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.

10. Fatty liver hepatitis and cirrhosis in obese patients.

Review 1. Practical management of the increasing burden of non-alcoholic fatty liver disease.

2. Orlistat reverse fatty infiltration and improves hepatic fibrosis in obese patients with nonalcoholic steatohepatitis (NASH).

3. Aggressive non-alcoholic steatohepatitis following rapid weight loss and/or malnutrition.

4. Effects of low-calorie diet on steatohepatitis in rats with obesity and hyperlipidemia.

Review 5. A growing burden: the pathogenesis, investigation and management of non-alcoholic fatty liver disease.

6. Steatosis and cirrhosis in an obese diabetic. Resolution of fatty liver by fasting.

7. Liver in obesity.

8. Hepatic adaptations to maintain metabolic homeostasis in response to fasting and refeeding in mice.

9. Clinical and histological features of nonalcoholic steatohepatitis in Iranian patients.